Related Experiment Video
Updated: May 1, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 27, 2013
Methodology and results of intravenous thrombolysis in acute myocardial infarction
Insights
Intravenous thrombolysis offers early reperfusion for acute myocardial infarction patients, but significant infarct size reduction is limited to early treatment. Its impact on mortality remains under investigation.
Area of Science:
- Cardiology
- Emergency Medicine
- Pharmacology
Background:
- Acute myocardial infarction (AMI) necessitates prompt reperfusion of ischemic heart muscle.
- Intravenous thrombolysis is the primary available therapy for early reperfusion in AMI.
- Thrombolytic agents like streptokinase and urokinase are used for coronary artery recanalization.
Purpose of the Study:
- To evaluate the efficacy of intravenous thrombolysis in acute myocardial infarction.
- To assess the impact of thrombolysis on infarct size and myocardial reperfusion.
- To review the current understanding of thrombolysis effects on AMI patient mortality.
Main Methods:
- Administration of short-term, high-dose intravenous infusions of streptokinase or urokinase.
- Monitoring of coronary artery recanalization rates.
- Assessment of infarct size reduction and bleeding risk.
- Review of existing data on early and late mortality outcomes.
Main Results:
- Achieved rapid recanalization in 50-60% of acute myocardial infarction patients.
- Demonstrated a low risk of bleeding associated with thrombolytic therapy.
- Substantial infarct size reduction was observed primarily in patients treated very early.
Conclusions:
- Intravenous thrombolysis is effective for early reperfusion in acute myocardial infarction.
- The benefit of thrombolysis on infarct size is most pronounced with early intervention.
- The overall impact of thrombolysis on acute myocardial infarction mortality requires further investigation through ongoing trials.
Abstract:
For the vast majority of patients with acute myocardial infarction, intravenous thrombolysis is at present the only therapeutic approach aimed at early reperfusion of the ischemic myocardium. Rapid recanalization of the infarct-related coronary artery is achieved in at least 50-60% of the patients by short-term high-dose infusions of streptokinase or urokinase with a low risk of bleeding. A substantial reduction of infarct size, however, can be expected in only a minority of patients, mostly in those who are treated very early. The effects of intravenous thrombolysis on early and late mortality from acute myocardial infarction are still equivocal; more conclusive data may be expected from ongoing randomized trials.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

